Global Cell Therapy and Gene Therapy CDMO Market Growth (Status and Outlook) 2025-2031

Report ID: 3036038 | Published Date: Jan 2026 | No. of Page: 113 | Base Year: 2025 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Scope of the Report
 1.1 Market Introduction
 1.2 Years Considered
 1.3 Research Objectives
 1.4 Market Research Methodology
 1.5 Research Process and Data Source
 1.6 Economic Indicators
 1.7 Currency Considered
 1.8 Market Estimation Caveats
2 Executive Summary
 2.1 World Market Overview
 2.1.1 Global Cell Therapy and Gene Therapy CDMO Market Size (2020-2031)
 2.1.2 Cell Therapy and Gene Therapy CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031)
 2.1.3 World Current & Future Analysis for Cell Therapy and Gene Therapy CDMO by Country/Region (2020, 2024 & 2031)
 2.2 Cell Therapy and Gene Therapy CDMO Segment by Type
 2.2.1 Cell Therapy
 2.2.2 Gene Therapy
 2.3 Cell Therapy and Gene Therapy CDMO Market Size by Type
 2.3.1 Cell Therapy and Gene Therapy CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031)
 2.3.2 Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2020-2025)
 2.4 Cell Therapy and Gene Therapy CDMO Segment by Application
 2.4.1 Clinical Stage Projects
 2.4.2 Commercialization Stage Projects
 2.5 Cell Therapy and Gene Therapy CDMO Market Size by Application
 2.5.1 Cell Therapy and Gene Therapy CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031)
 2.5.2 Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2020-2025)
3 Cell Therapy and Gene Therapy CDMO Market Size by Player
 3.1 Cell Therapy and Gene Therapy CDMO Market Size Market Share by Player
 3.1.1 Global Cell Therapy and Gene Therapy CDMO Revenue by Player (2020-2025)
 3.1.2 Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Player (2020-2025)
 3.2 Global Cell Therapy and Gene Therapy CDMO Key Players Head office and Products Offered
 3.3 Market Concentration Rate Analysis
 3.3.1 Competition Landscape Analysis
 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 3.4 New Products and Potential Entrants
 3.5 Mergers & Acquisitions, Expansion
4 Cell Therapy and Gene Therapy CDMO by Region
 4.1 Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025)
 4.2 Global Cell Therapy and Gene Therapy CDMO Annual Revenue by Country/Region (2020-2025)
 4.3 Americas Cell Therapy and Gene Therapy CDMO Market Size Growth (2020-2025)
 4.4 APAC Cell Therapy and Gene Therapy CDMO Market Size Growth (2020-2025)
 4.5 Europe Cell Therapy and Gene Therapy CDMO Market Size Growth (2020-2025)
 4.6 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Growth (2020-2025)
5 Americas
 5.1 Americas Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025)
 5.2 Americas Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025)
 5.3 Americas Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025)
 5.4 United States
 5.5 Canada
 5.6 Mexico
 5.7 Brazil
6 APAC
 6.1 APAC Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025)
 6.2 APAC Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025)
 6.3 APAC Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025)
 6.4 China
 6.5 Japan
 6.6 South Korea
 6.7 Southeast Asia
 6.8 India
 6.9 Australia
7 Europe
 7.1 Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025)
 7.2 Europe Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025)
 7.3 Europe Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025)
 7.4 Germany
 7.5 France
 7.6 UK
 7.7 Italy
 7.8 Russia
8 Middle East & Africa
 8.1 Middle East & Africa Cell Therapy and Gene Therapy CDMO by Region (2020-2025)
 8.2 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025)
 8.3 Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025)
 8.4 Egypt
 8.5 South Africa
 8.6 Israel
 8.7 Turkey
 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
 9.1 Market Drivers & Growth Opportunities
 9.2 Market Challenges & Risks
 9.3 Industry Trends
10 Global Cell Therapy and Gene Therapy CDMO Market Forecast
 10.1 Global Cell Therapy and Gene Therapy CDMO Forecast by Region (2026-2031)
 10.1.1 Global Cell Therapy and Gene Therapy CDMO Forecast by Region (2026-2031)
 10.1.2 Americas Cell Therapy and Gene Therapy CDMO Forecast
 10.1.3 APAC Cell Therapy and Gene Therapy CDMO Forecast
 10.1.4 Europe Cell Therapy and Gene Therapy CDMO Forecast
 10.1.5 Middle East & Africa Cell Therapy and Gene Therapy CDMO Forecast
 10.2 Americas Cell Therapy and Gene Therapy CDMO Forecast by Country (2026-2031)
 10.2.1 United States Market Cell Therapy and Gene Therapy CDMO Forecast
 10.2.2 Canada Market Cell Therapy and Gene Therapy CDMO Forecast
 10.2.3 Mexico Market Cell Therapy and Gene Therapy CDMO Forecast
 10.2.4 Brazil Market Cell Therapy and Gene Therapy CDMO Forecast
 10.3 APAC Cell Therapy and Gene Therapy CDMO Forecast by Region (2026-2031)
 10.3.1 China Cell Therapy and Gene Therapy CDMO Market Forecast
 10.3.2 Japan Market Cell Therapy and Gene Therapy CDMO Forecast
 10.3.3 Korea Market Cell Therapy and Gene Therapy CDMO Forecast
 10.3.4 Southeast Asia Market Cell Therapy and Gene Therapy CDMO Forecast
 10.3.5 India Market Cell Therapy and Gene Therapy CDMO Forecast
 10.3.6 Australia Market Cell Therapy and Gene Therapy CDMO Forecast
 10.4 Europe Cell Therapy and Gene Therapy CDMO Forecast by Country (2026-2031)
 10.4.1 Germany Market Cell Therapy and Gene Therapy CDMO Forecast
 10.4.2 France Market Cell Therapy and Gene Therapy CDMO Forecast
 10.4.3 UK Market Cell Therapy and Gene Therapy CDMO Forecast
 10.4.4 Italy Market Cell Therapy and Gene Therapy CDMO Forecast
 10.4.5 Russia Market Cell Therapy and Gene Therapy CDMO Forecast
 10.5 Middle East & Africa Cell Therapy and Gene Therapy CDMO Forecast by Region (2026-2031)
 10.5.1 Egypt Market Cell Therapy and Gene Therapy CDMO Forecast
 10.5.2 South Africa Market Cell Therapy and Gene Therapy CDMO Forecast
 10.5.3 Israel Market Cell Therapy and Gene Therapy CDMO Forecast
 10.5.4 Turkey Market Cell Therapy and Gene Therapy CDMO Forecast
 10.6 Global Cell Therapy and Gene Therapy CDMO Forecast by Type (2026-2031)
 10.7 Global Cell Therapy and Gene Therapy CDMO Forecast by Application (2026-2031)
 10.7.1 GCC Countries Market Cell Therapy and Gene Therapy CDMO Forecast
11 Key Players Analysis
 11.1 Lonza Pharmaceuticals
 11.1.1 Lonza Pharmaceuticals Company Information
 11.1.2 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Offered
 11.1.3 Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.1.4 Lonza Pharmaceuticals Main Business Overview
 11.1.5 Lonza Pharmaceuticals Latest Developments
 11.2 Thermo Fisher
 11.2.1 Thermo Fisher Company Information
 11.2.2 Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Offered
 11.2.3 Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.2.4 Thermo Fisher Main Business Overview
 11.2.5 Thermo Fisher Latest Developments
 11.3 catalent
 11.3.1 catalent Company Information
 11.3.2 catalent Cell Therapy and Gene Therapy CDMO Product Offered
 11.3.3 catalent Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.3.4 catalent Main Business Overview
 11.3.5 catalent Latest Developments
 11.4 Jubilant LifeSciences
 11.4.1 Jubilant LifeSciences Company Information
 11.4.2 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Offered
 11.4.3 Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.4.4 Jubilant LifeSciences Main Business Overview
 11.4.5 Jubilant LifeSciences Latest Developments
 11.5 Boehringer Ingelheim
 11.5.1 Boehringer Ingelheim Company Information
 11.5.2 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Offered
 11.5.3 Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.5.4 Boehringer Ingelheim Main Business Overview
 11.5.5 Boehringer Ingelheim Latest Developments
 11.6 Oxford BioMedica
 11.6.1 Oxford BioMedica Company Information
 11.6.2 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Offered
 11.6.3 Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.6.4 Oxford BioMedica Main Business Overview
 11.6.5 Oxford BioMedica Latest Developments
 11.7 Charles River
 11.7.1 Charles River Company Information
 11.7.2 Charles River Cell Therapy and Gene Therapy CDMO Product Offered
 11.7.3 Charles River Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.7.4 Charles River Main Business Overview
 11.7.5 Charles River Latest Developments
 11.8 WuXi AppTec
 11.8.1 WuXi AppTec Company Information
 11.8.2 WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Offered
 11.8.3 WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.8.4 WuXi AppTec Main Business Overview
 11.8.5 WuXi AppTec Latest Developments
 11.9 He Yuan Biology
 11.9.1 He Yuan Biology Company Information
 11.9.2 He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Offered
 11.9.3 He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.9.4 He Yuan Biology Main Business Overview
 11.9.5 He Yuan Biology Latest Developments
 11.10 GenScript Biotech
 11.10.1 GenScript Biotech Company Information
 11.10.2 GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Offered
 11.10.3 GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.10.4 GenScript Biotech Main Business Overview
 11.10.5 GenScript Biotech Latest Developments
 11.11 Kanglong Chemical
 11.11.1 Kanglong Chemical Company Information
 11.11.2 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Offered
 11.11.3 Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.11.4 Kanglong Chemical Main Business Overview
 11.11.5 Kanglong Chemical Latest Developments
 11.12 Porton shares
 11.12.1 Porton shares Company Information
 11.12.2 Porton shares Cell Therapy and Gene Therapy CDMO Product Offered
 11.12.3 Porton shares Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.12.4 Porton shares Main Business Overview
 11.12.5 Porton shares Latest Developments
 11.13 Sano Biologics
 11.13.1 Sano Biologics Company Information
 11.13.2 Sano Biologics Cell Therapy and Gene Therapy CDMO Product Offered
 11.13.3 Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.13.4 Sano Biologics Main Business Overview
 11.13.5 Sano Biologics Latest Developments
 11.14 Yunzhou Biology
 11.14.1 Yunzhou Biology Company Information
 11.14.2 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Offered
 11.14.3 Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.14.4 Yunzhou Biology Main Business Overview
 11.14.5 Yunzhou Biology Latest Developments
12 Research Findings and Conclusion

List of Tables
 Table 1. Cell Therapy and Gene Therapy CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Cell Therapy and Gene Therapy CDMO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Cell Therapy
 Table 4. Major Players of Gene Therapy
 Table 5. Cell Therapy and Gene Therapy CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 6. Global Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025) & ($ millions)
 Table 7. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2020-2025)
 Table 8. Cell Therapy and Gene Therapy CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 9. Global Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025) & ($ millions)
 Table 10. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2020-2025)
 Table 11. Global Cell Therapy and Gene Therapy CDMO Revenue by Player (2020-2025) & ($ millions)
 Table 12. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Player (2020-2025)
 Table 13. Cell Therapy and Gene Therapy CDMO Key Players Head office and Products Offered
 Table 14. Cell Therapy and Gene Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 15. New Products and Potential Entrants
 Table 16. Mergers & Acquisitions, Expansion
 Table 17. Global Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & ($ millions)
 Table 18. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2020-2025)
 Table 19. Global Cell Therapy and Gene Therapy CDMO Revenue by Country/Region (2020-2025) & ($ millions)
 Table 20. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Country/Region (2020-2025)
 Table 21. Americas Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & ($ millions)
 Table 22. Americas Cell Therapy and Gene Therapy CDMO Market Size Market Share by Country (2020-2025)
 Table 23. Americas Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025) & ($ millions)
 Table 24. Americas Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2020-2025)
 Table 25. Americas Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025) & ($ millions)
 Table 26. Americas Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2020-2025)
 Table 27. APAC Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & ($ millions)
 Table 28. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2020-2025)
 Table 29. APAC Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025) & ($ millions)
 Table 30. APAC Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025) & ($ millions)
 Table 31. Europe Cell Therapy and Gene Therapy CDMO Market Size by Country (2020-2025) & ($ millions)
 Table 32. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Country (2020-2025)
 Table 33. Europe Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025) & ($ millions)
 Table 34. Europe Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025) & ($ millions)
 Table 35. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Region (2020-2025) & ($ millions)
 Table 36. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Type (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size by Application (2020-2025) & ($ millions)
 Table 38. Key Market Drivers & Growth Opportunities of Cell Therapy and Gene Therapy CDMO
 Table 39. Key Market Challenges & Risks of Cell Therapy and Gene Therapy CDMO
 Table 40. Key Industry Trends of Cell Therapy and Gene Therapy CDMO
 Table 41. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 42. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share Forecast by Region (2026-2031)
 Table 43. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 44. Global Cell Therapy and Gene Therapy CDMO Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 45. Lonza Pharmaceuticals Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 46. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Product Offered
 Table 47. Lonza Pharmaceuticals Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 48. Lonza Pharmaceuticals Main Business
 Table 49. Lonza Pharmaceuticals Latest Developments
 Table 50. Thermo Fisher Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 51. Thermo Fisher Cell Therapy and Gene Therapy CDMO Product Offered
 Table 52. Thermo Fisher Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 53. Thermo Fisher Main Business
 Table 54. Thermo Fisher Latest Developments
 Table 55. catalent Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 56. catalent Cell Therapy and Gene Therapy CDMO Product Offered
 Table 57. catalent Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 58. catalent Main Business
 Table 59. catalent Latest Developments
 Table 60. Jubilant LifeSciences Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 61. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Product Offered
 Table 62. Jubilant LifeSciences Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 63. Jubilant LifeSciences Main Business
 Table 64. Jubilant LifeSciences Latest Developments
 Table 65. Boehringer Ingelheim Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 66. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Product Offered
 Table 67. Boehringer Ingelheim Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 68. Boehringer Ingelheim Main Business
 Table 69. Boehringer Ingelheim Latest Developments
 Table 70. Oxford BioMedica Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 71. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Product Offered
 Table 72. Oxford BioMedica Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 73. Oxford BioMedica Main Business
 Table 74. Oxford BioMedica Latest Developments
 Table 75. Charles River Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 76. Charles River Cell Therapy and Gene Therapy CDMO Product Offered
 Table 77. Charles River Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 78. Charles River Main Business
 Table 79. Charles River Latest Developments
 Table 80. WuXi AppTec Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 81. WuXi AppTec Cell Therapy and Gene Therapy CDMO Product Offered
 Table 82. WuXi AppTec Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 83. WuXi AppTec Main Business
 Table 84. WuXi AppTec Latest Developments
 Table 85. He Yuan Biology Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 86. He Yuan Biology Cell Therapy and Gene Therapy CDMO Product Offered
 Table 87. He Yuan Biology Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 88. He Yuan Biology Main Business
 Table 89. He Yuan Biology Latest Developments
 Table 90. GenScript Biotech Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 91. GenScript Biotech Cell Therapy and Gene Therapy CDMO Product Offered
 Table 92. GenScript Biotech Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 93. GenScript Biotech Main Business
 Table 94. GenScript Biotech Latest Developments
 Table 95. Kanglong Chemical Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 96. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Product Offered
 Table 97. Kanglong Chemical Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 98. Kanglong Chemical Main Business
 Table 99. Kanglong Chemical Latest Developments
 Table 100. Porton shares Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 101. Porton shares Cell Therapy and Gene Therapy CDMO Product Offered
 Table 102. Porton shares Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 103. Porton shares Main Business
 Table 104. Porton shares Latest Developments
 Table 105. Sano Biologics Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 106. Sano Biologics Cell Therapy and Gene Therapy CDMO Product Offered
 Table 107. Sano Biologics Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 108. Sano Biologics Main Business
 Table 109. Sano Biologics Latest Developments
 Table 110. Yunzhou Biology Details, Company Type, Cell Therapy and Gene Therapy CDMO Area Served and Its Competitors
 Table 111. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Product Offered
 Table 112. Yunzhou Biology Cell Therapy and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 113. Yunzhou Biology Main Business
 Table 114. Yunzhou Biology Latest Developments


List of Figures
 Figure 1. Cell Therapy and Gene Therapy CDMO Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Cell Therapy and Gene Therapy CDMO Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Cell Therapy and Gene Therapy CDMO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Cell Therapy and Gene Therapy CDMO Sales Market Share by Country/Region (2024)
 Figure 8. Cell Therapy and Gene Therapy CDMO Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type in 2024
 Figure 10. Cell Therapy and Gene Therapy CDMO in Clinical Stage Projects
 Figure 11. Global Cell Therapy and Gene Therapy CDMO Market: Clinical Stage Projects (2020-2025) & ($ millions)
 Figure 12. Cell Therapy and Gene Therapy CDMO in Commercialization Stage Projects
 Figure 13. Global Cell Therapy and Gene Therapy CDMO Market: Commercialization Stage Projects (2020-2025) & ($ millions)
 Figure 14. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application in 2024
 Figure 15. Global Cell Therapy and Gene Therapy CDMO Revenue Market Share by Player in 2024
 Figure 16. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2020-2025)
 Figure 17. Americas Cell Therapy and Gene Therapy CDMO Market Size 2020-2025 ($ millions)
 Figure 18. APAC Cell Therapy and Gene Therapy CDMO Market Size 2020-2025 ($ millions)
 Figure 19. Europe Cell Therapy and Gene Therapy CDMO Market Size 2020-2025 ($ millions)
 Figure 20. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size 2020-2025 ($ millions)
 Figure 21. Americas Cell Therapy and Gene Therapy CDMO Value Market Share by Country in 2024
 Figure 22. United States Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 23. Canada Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 24. Mexico Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 25. Brazil Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 26. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region in 2024
 Figure 27. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2020-2025)
 Figure 28. APAC Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2020-2025)
 Figure 29. China Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 30. Japan Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 31. South Korea Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 32. Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 33. India Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 34. Australia Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 35. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Country in 2024
 Figure 36. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2020-2025)
 Figure 37. Europe Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2020-2025)
 Figure 38. Germany Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 39. France Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 40. UK Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 41. Italy Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 42. Russia Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 43. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Market Share by Region (2020-2025)
 Figure 44. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Market Share by Type (2020-2025)
 Figure 45. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size Market Share by Application (2020-2025)
 Figure 46. Egypt Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 47. South Africa Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 48. Israel Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 49. Turkey Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 50. GCC Countries Cell Therapy and Gene Therapy CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 51. Americas Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 52. APAC Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 53. Europe Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 54. Middle East & Africa Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 55. United States Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 56. Canada Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 57. Mexico Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 58. Brazil Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 59. China Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 60. Japan Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 61. Korea Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 62. Southeast Asia Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 63. India Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 64. Australia Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 65. Germany Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 66. France Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 67. UK Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 68. Italy Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 69. Russia Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 70. Egypt Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 71. South Africa Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 72. Israel Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 73. Turkey Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
 Figure 74. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share Forecast by Type (2026-2031)
 Figure 75. Global Cell Therapy and Gene Therapy CDMO Market Size Market Share Forecast by Application (2026-2031)
 Figure 76. GCC Countries Cell Therapy and Gene Therapy CDMO Market Size 2026-2031 ($ millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lonza Pharmaceuticals|||Thermo Fisher|||catalent|||Jubilant LifeSciences|||Boehringer Ingelheim|||Oxford BioMedica|||Charles River|||WuXi AppTec|||He Yuan Biology|||GenScript Biotech|||Kanglong Chemical|||Porton shares|||Sano Biologics|||Yunzhou Biology
Frequently Asked Questions
Cell Therapy and Gene Therapy CDMO report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cell Therapy and Gene Therapy CDMO report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cell Therapy and Gene Therapy CDMO report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports